In this daily bar chart of RXN, below, we can see that prices have been in an uptrend over the past year. The pattern of higher highs and higher lows is slow and steady until November/December when investors hit the gas pedal and prices rally above the 50-day moving average line and the make a successful retest of the rising 200-day line. The On-Balance-Volume (OBV) line shows a nice advance from the middle of November but it has been positive all year. The Moving Average Convergence Divergence (MACD) oscillator moved above the zero line in December for an outright go long signal but the two moving average lines have narrowed towards a possible take profits sell signal.
In this weekly bar chart of RXN, below, we can see that prices have doubled from their 2016 nadir. Prices are above the rising 40-week moving average line . The weekly OBV line has been moving up since December 2016 but has yet to made a new high to confirm the new price highs on RXN. The weekly MACD oscillator in the lower panel crossed to the upside in December for an outright go signal.
In this Point and Figure chart of RXN, below, we can see that a trade at $31.00 will be an important upside breakout. A $33.50 price target is shown but gains to the mid $40's are possible using other techniques.
Bottom line -- no one investing approach is perfect or 100% so it pays to pay attention to fundamental and quantitative upgrades and downgrades. RXN looks attractive on two counts. Aggressive traders could go long RXN on available weakness towards $27.50 risking a close below $26.00. The $33 area and the mid-$40's are my potential price targets.